HiCisco (002653.SZ): HSK 39297 film marketing license accepted

Zhitongcaijing · 2d ago

Zhitong Financial App News, Hi-Cisco (002653.SZ) announced that the company's subsidiary, Sichuan Hisco Pharmaceutical Co., Ltd. received the “Notice of Acceptance” issued by the State Drug Administration on January 6, 2026. The relevant drug name is: HSK39297 tablets. The application indications are: suitable for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have not previously been treated with complement inhibitors.